Protalix BioTherapeutics
PLX
#8648
Rank
C$0.10 B
Marketcap
$1.49
Share price
-4.35%
Change (1 day)
-35.23%
Change (1 year)

Protalix BioTherapeutics (PLX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : C$85.39 M

According to Protalix BioTherapeutics 's latest financial reports the company's total liabilities are C$85.39 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Protalix BioTherapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$67.46 M-25.15%
2022-12-31C$90.13 M-10.64%
2021-12-31C$0.10 B-16.71%
2020-12-31C$0.12 B-19.26%
2019-12-31C$0.15 B-3.55%
2018-12-31C$0.15 B21.67%
2017-12-31C$0.12 B3.16%
2016-12-31C$0.12 B3.3%
2015-12-31C$0.11 B-22.79%
2014-12-31C$0.15 B4.11%
2013-12-31C$0.14 B82.42%
2012-12-31C$81.8 M3.27%
2011-12-31C$79.22 M4.07%
2010-12-31C$76.12 M-12.72%
2009-12-31C$87.21 M1004.26%
2008-12-31C$7.89 M80.95%
2007-12-31C$4.36 M38.65%
2006-12-31C$3.14 M139.3%
2005-12-31C$1.31 M1598.16%
2004-12-31C$0.07 M-25.02%
2003-12-31C$0.1 M-17.27%
2002-12-31C$0.12 M1.45%
2001-12-31C$0.12 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$0.83 B 879.94%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.07 B 1,164.00%๐Ÿ‡บ๐Ÿ‡ธ USA
C$173.91 B 203,553.17%๐Ÿ‡บ๐Ÿ‡ธ USA
C$47.16 B 55,134.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel